HomeNEU • ASX
add
Neuren Pharmaceuticals Ltd
Nakaraang pagsara
$20.69
Sakop ng araw
$19.20 - $20.60
Sakop ng taon
$8.61 - $22.99
Market cap
2.56B AUD
Average na Volume
369.02K
P/E ratio
17.72
Dividend yield
-
Primary exchange
ASX
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 14.14M | 7.73% |
Gastos sa pagpapatakbo | 1.24M | 4.59% |
Net na kita | 7.52M | 87.51% |
Net profit margin | 53.16 | 74.07% |
Kita sa bawat share | — | — |
EBITDA | 5.45M | 81.95% |
Aktuwal na % ng binabayarang buwis | 23.78% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 299.54M | 40.51% |
Kabuuang asset | 331.25M | 45.19% |
Kabuuang sagutin | 7.98M | -11.35% |
Kabuuang equity | 323.27M | — |
Natitirang share | 124.49M | — |
Presyo para makapag-book | 7.96 | — |
Return on assets | 4.11% | — |
Return on capital | 4.21% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 7.52M | 87.51% |
Cash mula sa mga operasyon | 64.15M | 724.79% |
Cash mula sa pag-invest | -42.79M | -10,287.26% |
Cash mula sa financing | -19.10M | -2,414.23% |
Net change in cash | 1.38M | 118.96% |
Malayang cash flow | 3.66M | 62.39% |
Tungkol
CEO
Itinatag
2001
Website
Mga Empleyado
8
